We have two initial public offerings today. We have a poor pricing from Addus HomeCare Corporation (NASDAQ: ADUS) and a solid pricing from a Blackstone interest in the Vitamin Shoppe Inc. (NYSE: VSI) IPO.
Addus HomeCare Corporation (NASDAQ: ADUS) is joining the realm of disappointing initial public offerings. The home-based medical and social service company, which would seem to be a big growth segment ahead, priced its 5 million share IPO at $10.00 per share. This is below the $11.00 to $12.00 range. Robert W. Baird and Oppenheimer & Co. were joint book-running managers, and Stephens Inc. was listed as the co-manager.
Vitamin Shoppe Inc. (NYSE: VSI) actually looks like it broke the poor IPO trend. This company, which sells vitamins and supplements priced its 9.096 million share IPO at $17.00. This one is ABOVE the $14.00 to $16.00 per share range in an IPO being brought public by J.P. Morgan, BofA Merrill Lynch, and Barclays. The Blackstone Group (NYSE: BX) is a holder of this company.
You can join our open email distribution list to get updates on top analyst upgrades and downgrades, top day trader alerts, IPO’s, secondary offerings, Warren Buffett and other guru activity, M&A and more.
JON C. OGG
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
